公开(公告)号：US20200009101A1

公开(公告)日：2020-01-09

申请号：US16486381

申请日：2018-02-13

Applicant: VALBIOTIS ,  UNIVERSITE CLERMONT AUVERGNE ,  UNIVERSITE DE LA ROCHELLE ,  CNRS

Inventor： Sebastien PELTIER ,  Vivien CHAVANELLE ,  Florian LE JOUBIOUX ,  Pascal SIRVENT ,  Thierry MAUGARD

IPC: A61K31/216 ,  A61K31/7048 ,  A61P3/04 ,  A61P3/06 ,  A61P3/10

Abstract: The invention relates to an active pharmaceutical ingredient consisting exclusively of the combination of (1S,3R,4R,5R)-3-{[(2E)-3-(3,4-)dihydroxyphenyl)-2-propenoyl]oxy}-1,4,5-trihydroxycyclohexanecarboxylic acid and of methyl (2S,3E,4S)-4-{2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl}-3-ethylidene-2-(β-D-glucopyranosyloxy)-3,4-dihydro-2H -pyran-5-carboxylate for use as a drug or veterinary product, particularly in the prevention and/or treatment of pathological disorders of carbohydrate and/or lipid metabolism.

公开(公告)号：US20220257685A1

公开(公告)日：2022-08-18

申请号：US17618013

申请日：2020-06-11

Applicant: VALBIOTIS

Inventor： Sébastien PELTIER ,  Pascal SIRVENT ,  Yolanda OTERO

IPC: A61K36/287 ,  A61K36/28 ,  A61K36/45 ,  A61K31/7048 ,  A61K45/06 ,  A61P1/12

Abstract: The invention relates to a composition comprising at least: an extract of Chrysanthellum, and an extract of artichoke, and an extract of blueberry, and an extract of at least one plant-derived raw material comprising oleuropein, and optionally synthetic piperine and/or an extract of at least one plant-derived raw material comprising piperine, for use as a drug or nutritional product in the prevention and/or treatment of chronic inflammatory bowel disease in humans or animals.